153 related articles for article (PubMed ID: 35563019)
21. Purification and characterization of a naturally processed hepatitis B virus peptide recognized by CD8+ cytotoxic T lymphocytes.
Tsai SL; Chen MH; Yeh CT; Chu CM; Lin AN; Chiou FH; Chang TH; Liaw YF
J Clin Invest; 1996 Jan; 97(2):577-84. PubMed ID: 8567982
[TBL] [Abstract][Full Text] [Related]
22. Selection of peptides that bind to the HLA-A2.1 molecule by molecular modelling.
Lim JS; Kim S; Lee HG; Lee KY; Kwon TJ; Kim K
Mol Immunol; 1996 Feb; 33(2):221-30. PubMed ID: 8649443
[TBL] [Abstract][Full Text] [Related]
23. In vivo hierarchy of immunodominant and subdominant HLA-A*0201-restricted T-cell epitopes of HBx antigen of hepatitis B virus.
Malmassari S; Lone YC; Zhang M; Transy C; Michel ML
Microbes Infect; 2005 Apr; 7(4):626-34. PubMed ID: 15820153
[TBL] [Abstract][Full Text] [Related]
24. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen.
Penna A; Chisari FV; Bertoletti A; Missale G; Fowler P; Giuberti T; Fiaccadori F; Ferrari C
J Exp Med; 1991 Dec; 174(6):1565-70. PubMed ID: 1720813
[TBL] [Abstract][Full Text] [Related]
25. Immunization with the HBV core 18-27 epitope elicits CTL responses in humans expressing different HLA-A2 supertype molecules.
Livingston BD; Crimi C; Fikes J; Chesnut RW; Sidney J; Sette A
Hum Immunol; 1999 Nov; 60(11):1013-7. PubMed ID: 10599997
[TBL] [Abstract][Full Text] [Related]
26. Prediction of HLA class I-restricted T-cell epitopes of islet autoantigen combined with binding and dissociation assays.
Wu X; Xu X; Gu R; Wang Z; Chen H; Xu K; Zhang M; Hutton J; Yang T
Autoimmunity; 2012 Mar; 45(2):176-85. PubMed ID: 22260783
[TBL] [Abstract][Full Text] [Related]
27. Identification of hepatitis B virus-specific CTL epitopes presented by HLA-A*33:03 in peripheral blood mononuclear cells from patients and transgenic mice.
Pan X; Ding H; Zhou X; Tien P
Biochem Biophys Res Commun; 2014 Jun; 449(1):135-40. PubMed ID: 24813999
[TBL] [Abstract][Full Text] [Related]
28. [Prediction synthesis and identification of HLA-A2-restricted cytotoxic T lymphocyte epitopes of the tumor antigen MAGE-n].
Dong HL; Sui YF; Ye J; Li ZS; Qu P; Zhang XM; Chen GS; Lu SY
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(12):1080-3. PubMed ID: 12899783
[TBL] [Abstract][Full Text] [Related]
29. High frequency of functional anti-YMDD and -mutant cytotoxic T lymphocytes after in vitro expansion correlates with successful response to lamivudine therapy for chronic hepatitis B.
Lin CL; Tsai SL; Lee TH; Chien RN; Liao SK; Liaw YF
Gut; 2005 Jan; 54(1):152-61. PubMed ID: 15591521
[TBL] [Abstract][Full Text] [Related]
30. CD8
Qiu C; Xiao C; Wang Z; Zhu G; Mao L; Chen X; Gao L; Deng J; Su J; Su H; Fang EF; Zhang ZJ; Zhang J; Xie C; Yuan J; Luo OJ; Huang LA; Wang P; Chen G
Front Immunol; 2021; 12():764949. PubMed ID: 35116022
[TBL] [Abstract][Full Text] [Related]
31. Using structural analysis to explore the role of hepatitis B virus mutations in immune escape from liver cancer in Chinese, European and American populations.
Gu S; Lv L; Lin X; Li X; Dai J; Zhang J; Kong R; Xie W; Li J
J Biomol Struct Dyn; 2022 Mar; 40(4):1586-1596. PubMed ID: 33030111
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxic T-lymphocyte elicited therapeutic vaccine candidate targeting cancer against MAGE-A11 carcinogenic protein.
Kumar N; Sood D; Gupta A; Jha NK; Jain P; Chandra R
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33169789
[TBL] [Abstract][Full Text] [Related]
33. [Transgenic expression of T cell receptors on HBV-specific cytotoxic T lymphocytes].
Wu J; Wang L; Liu Y; Ye H; Ding N; Liu Y; Xu D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 May; 29(5):453-7. PubMed ID: 23643259
[TBL] [Abstract][Full Text] [Related]
34. DCs pulsed with novel HLA-A2-restricted CTL epitopes against hepatitis C virus induced a broadly reactive anti-HCV-specific T lymphocyte response.
Guo Z; Zhang H; Rao H; Jiang D; Cong X; Feng B; Wang J; Wei L; Chen H
PLoS One; 2012; 7(6):e38390. PubMed ID: 22701633
[TBL] [Abstract][Full Text] [Related]
35. [Direct analysis of HBV-specific CD8+ lymphocyte by tetrameric HLA-A2/core 18-27 complex in chronic Hepatitis B].
Lee CK; Suh JH; Cho YS; Han KH; Chung JB; Chon CY; Moon YM
Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):139-48. PubMed ID: 12499799
[TBL] [Abstract][Full Text] [Related]
36. TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection.
Wang H; Luo H; Wan X; Fu X; Mao Q; Xiang X; Zhou Y; He W; Zhang J; Guo Y; Tan W; Deng G
J Hepatol; 2020 Jan; 72(1):45-56. PubMed ID: 31499130
[TBL] [Abstract][Full Text] [Related]
37. Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18-27: interaction with HLA and T-cell receptor.
Bertoletti A; Southwood S; Chesnut R; Sette A; Falco M; Ferrara GB; Penna A; Boni C; Fiaccadori F; Ferrari C
Hepatology; 1997 Oct; 26(4):1027-34. PubMed ID: 9328331
[TBL] [Abstract][Full Text] [Related]
38. Development of a novel in silico docking simulation model for the fine HIV-1 cytotoxic T lymphocyte epitope mapping.
Mori M; Matsuki K; Maekawa T; Tanaka M; Sriwanthana B; Yokoyama M; Ariyoshi K
PLoS One; 2012; 7(7):e41703. PubMed ID: 22848572
[TBL] [Abstract][Full Text] [Related]
39. Peptide-specific CTL induction in HBV-seropositive PBMC by stimulation with peptides in vitro: novel epitopes identified from chronic carriers.
Lee HG; Lim JS; Lee KY; Choi YK; Choe IS; Chung TW; Kim K
Virus Res; 1997 Aug; 50(2):185-94. PubMed ID: 9282783
[TBL] [Abstract][Full Text] [Related]
40. Identification of HLA-A*0201-restricted cytotoxic T lymphocyte epitope from TRAG-3 antigen.
Zhu B; Chen Z; Cheng X; Lin Z; Guo J; Jia Z; Zou L; Wang Z; Hu Y; Wang D; Wu Y
Clin Cancer Res; 2003 May; 9(5):1850-7. PubMed ID: 12738743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
